The 6th Due Diligence Summit for Life Sciences

Memo

Over the last five years, this summit has provided due diligence professionals with a platform to explore innovative models and deal structures for collaborating with strategic partners, and discussed valuable strategies for conducting efficient and effective due diligence. Join your peers at the 6th Due Diligence Summit for Life Sciences for the opportunity to network and engage with some of the industry’s leading experts. Top Five Reasons to Attend1. Gain valuable insight from cross-functional due diligence team members, as well as leaders in the medical device and biotech industries2. Understand how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal3. Learn how to evaluate and effectively manage strategic alliances through case studies from industry leaders4. Explore best practices for companies of all sizes looking to acquire or in-license a product5. Discover the impact company culture can have on the success of integrating the workforce post-merger or acquisition This conference features practical insights and best practices for optimizing due diligence processes when evaluating M&A, strategic alliances, and licensing deals, and serves as a platform for cross-functional professionals from biotech and big pharma companies to address the challenges they face in their day-to-day jobs.